Nom du produit:3-(4-((2-Aminoethyl)amino)-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one hydroiodide

IUPAC Name:3-{4-[(2-aminoethyl)amino]-1,2,5-oxadiazol-3-yl}-4-(3-bromo-4-fluorophenyl)-4,5-dihydro-1,2,4-oxadiazol-5-one hydroiodide

CAS:1204669-57-7
Formule moléculaire:C12H11BrFIN6O3
Pureté:95%
Numéro de catalogue:CM182739
Poids moléculaire:513.07

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1204669-57-7
Formule moléculaire:C12H11BrFIN6O3
Point de fusion:-
Code SMILES:O=C1N(C2=CC=C(F)C(Br)=C2)C(C3=NON=C3NCCN)=NO1.[H]I
Densité:
Numéro de catalogue:CM182739
Poids moléculaire:513.07
Point d'ébullition:
N° Mdl:MFCD27996217
Stockage:Store at 2-8°C.

Category Infos

Furazans
Incorporation of heterocycles into drug molecules can enhance physical properties and biological activity. Oxadiazoles are a class of five-membered heterocycles containing one oxygen and two nitrogen atoms with special biological activity and thermodynamic properties. 1,2,4- and 1,3,4-oxadiazoles are widely used in the development of bioactive molecules, but 1,2,5-oxadiazoles (furazans) are used relatively sparingly. Compared with 1,2,4- and 1,3,4-isomers, 1,2,5-oxadiazole has unique physicochemical properties and electronic effects. The furazan ring has a strong inductive effect, comparable to that of trifluoromethyl or tetrazolyl. The unique properties of furoxan can confer specific pharmacological activities to drug-like molecules.